Lou-Gehrigs Disease
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS (NCT03520517) | Biohaven Pharmaceuticals, Inc. | 2018-02-02 |
| Genetic Study of Familial and Sporadic ALS/Motor Neuron Disease, Miyoshi Myopathy and Other Neuromuscular Disorders (NCT01459302) | University of Massachusetts, Worcester | 2009-01-01 |
| Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) (NCT03537807) | Biohaven Pharmaceuticals, Inc. |
Track Lou-Gehrigs Disease automatically
Every clearance here is in the API, with alerts when new ones post.